These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3039132)

  • 1. Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents.
    Hagedorn AA; Erhardt PW; Lumma WC; Wohl RA; Cantor E; Chou YL; Ingebretsen WR; Lampe JW; Pang D; Pease CA
    J Med Chem; 1987 Aug; 30(8):1342-7. PubMed ID: 3039132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotonic agents. 1. Novel 8-aryl-substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents.
    Davey D; Erhardt PW; Lumma WC; Wiggins J; Sullivan M; Pang D; Cantor E
    J Med Chem; 1987 Aug; 30(8):1337-42. PubMed ID: 3039131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.
    Sircar I; Steffen RP; Bobowski G; Burke SE; Newton RS; Weishaar RE; Bristol JA; Evans DB
    J Med Chem; 1989 Feb; 32(2):342-50. PubMed ID: 2536438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotonic agents. 5. Fragments from the heterocycle-phenyl-imidazole pharmacophore.
    Erhardt PW; Hagedorn AA; Davey D; Pease CA; Venepalli BR; Griffin CW; Gomez RP; Wiggins JR; Ingebretsen WR; Pang D
    J Med Chem; 1989 Jun; 32(6):1173-6. PubMed ID: 2542552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cardiotonic activity of a series of substituted 4-alkyl-2(1H)-quinazolinones.
    Bandurco VT; Schwender CF; Bell SC; Combs DW; Kanojia RM; Levine SD; Mulvey DM; Appollina MA; Reed MS; Malloy EA
    J Med Chem; 1987 Aug; 30(8):1421-6. PubMed ID: 3039135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
    Sircar I; Duell BL; Bobowski G; Bristol JA; Evans DB
    J Med Chem; 1985 Oct; 28(10):1405-13. PubMed ID: 2864447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents.
    Combs DW; Rampulla MS; Bell SC; Klaubert DH; Tobia AJ; Falotico R; Haertlein B; Lakas-Weiss C; Moore JB
    J Med Chem; 1990 Jan; 33(1):380-6. PubMed ID: 2153210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
    Schnettler RA; Dage RC; Grisar JM
    J Med Chem; 1982 Dec; 25(12):1477-81. PubMed ID: 7154009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Imidazolylphenyl)pyrrol-2-one inhibitors of cardiac cAMP phosphodiesterase.
    Lampe JW; Chou YL; Hanna RG; Di Meo SV; Erhardt PW; Hagedorn AA; Ingebretsen WR; Cantor E
    J Med Chem; 1993 Apr; 36(8):1041-7. PubMed ID: 8386770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
    Endoh M; Yanagisawa T; Morita T; Taira N
    J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the cardiovascular and biochemical profiles of a new positive inotropic drug, AR-L 115 BS, with those of theophylline.
    Morita T; Satoh K; Taira N
    Jpn Heart J; 1984 May; 25(3):447-60. PubMed ID: 6088829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activity.
    Sircar I; Weishaar RE; Kobylarz D; Moos WH; Bristol JA
    J Med Chem; 1987 Nov; 30(11):1955-62. PubMed ID: 2822926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cardiotonic activity of novel biimidazoles.
    Matthews DP; McCarthy JR; Whitten JP; Kastner PR; Barney CL; Marshall FN; Ertel MA; Burkhard T; Shea PJ; Kariya T
    J Med Chem; 1990 Jan; 33(1):317-27. PubMed ID: 2153209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic-AMP-dependent positive chrono- and inotropic responses in the blood-perfused dog atrium.
    Chiba S; Karasawa Y; Furukawa Y
    Adv Second Messenger Phosphoprotein Res; 1992; 25():363-72. PubMed ID: 1372814
    [No Abstract]   [Full Text] [Related]  

  • 15. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
    Alvarez R; Banerjee GL; Bruno JJ; Jones GL; Littschwager K; Strosberg AM; Venuti MC
    Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)spiro[cycloalkane- 1,3'-[3H]indol]-2'(1'H)-ones.
    Robertson DW; Krushinski JH; Pollock GD; Wilson H; Kauffman RF; Hayes JS
    J Med Chem; 1987 May; 30(5):824-9. PubMed ID: 3033241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular responses to a newly developed phosphodiesterase inhibitor, DN-9693 [7-pyperidinyl-1,2,3,5-tetrahydroimidazo (2,1-b)-quinazolin-2-one.HCl] in dog cross-circulated atrial and ventricular preparations.
    Akahane K; Furukawa Y; Haniuda M; Karasawa Y; Chiba S
    Jpn Heart J; 1989 Nov; 30(6):903-15. PubMed ID: 2561162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
    Juan-Fita MJ; Vargas ML; Hernández J
    Eur J Pharmacol; 2005 Apr; 512(2-3):207-13. PubMed ID: 15840406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
    Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotonic agents. 5. 1,2-Dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-6-methyl-2-oxo-3- pyridinecarbonitriles and related compounds. Synthesis and inotropic activity.
    Sircar I; Duell BL; Bristol JA; Weishaar RE; Evans DB
    J Med Chem; 1987 Jun; 30(6):1023-9. PubMed ID: 3585900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.